Massachusetts Financial Services
ITOS

Massachusetts Financial Services’s iTeos Therapeutics ITOS Stock Holding History

Massachusetts Financial Services’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,662
Closed -$242K – 901
2024
Q3 		$242K Buy
+23,662
New +$361K ﹤0.01% 835
2024
Q2 		– Sell
-75,678
Closed -$1.03M – 879
2024
Q1 		$1.03M Sell
75,678
-168
-0.2% -$1.83K ﹤0.01% 786
2023
Q4 		$831K Sell
75,846
-2,397
-3% -$23.8K ﹤0.01% 784
2023
Q3 		$857K Sell
78,243
-2,998
-4% -$38.3K ﹤0.01% 779
2023
Q2 		$1.08M Sell
81,241
-1,913
-2% -$27.3K ﹤0.01% 750
2023
Q1 		$1.13M Sell
83,154
-40,708
-33% -$729K ﹤0.01% 749
2022
Q4 		$2.42M Buy
123,862
+2,622
+2% +$51.2K ﹤0.01% 705
2022
Q3 		$2.31M Sell
121,240
-1,106
-0.9% -$25.5K ﹤0.01% 706
2022
Q2 		$2.52M Buy
122,346
+70,959
+138% +$1.68M ﹤0.01% 697
2022
Q1 		$1.65M Buy
51,387
+26,558
+107% +$965K ﹤0.01% 769
2021
Q4 		$1.16M Buy
+24,829
New +$827K ﹤0.01% 810

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Massachusetts Financial Services's ITOS Position: Q4 2024 in Review

Massachusetts Financial Services sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 23,662 shares — an estimated $242K sold.

Massachusetts Financial Services first reported a position in ITOS in Q4 2021 and held it in 11 quarters. The position peaked at $2.52M in Q2 2022. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Massachusetts Financial Services reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 23,662 iTeos Therapeutics shares in Q4 2024, an estimated $242K.
  • Massachusetts Financial Services first reported a position in iTeos Therapeutics in Q4 2021 and held it in 11 quarters.
  • Massachusetts Financial Services's iTeos Therapeutics position peaked at $2.52M in Q2 2022.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.